G

Gemina Laboratories Ltd
CNSX:GLAB

Watchlist Manager
Gemina Laboratories Ltd
CNSX:GLAB
Watchlist
Price: 0.04 CAD Market Closed
Market Cap: CA$3.1m

Gemina Laboratories Ltd
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Gemina Laboratories Ltd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
G
Gemina Laboratories Ltd
CNSX:GLAB
Research & Development
-CA$1.2m
CAGR 3-Years
-6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
BioMark Diagnostics Inc
CNSX:BUX
Research & Development
-CA$616.8k
CAGR 3-Years
2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
MedMira Inc
XTSX:MIR
Research & Development
-CA$965.6k
CAGR 3-Years
-43%
CAGR 5-Years
-34%
CAGR 10-Years
3%
No Stocks Found

Gemina Laboratories Ltd
Glance View

Market Cap
3.1m CAD
Industry
N/A

Gemina Laboratories Ltd. (Gemina) is a Canada-based biotechnology company. Gemina operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. It is engaged in biosensor and diagnostic services with a transformative, patented, proprietary chemistry that powers next-generation testing platforms for a wide range of pathogens that affect human health and wellness. Gemina's technology drives testing platforms that are fast, affordable and accurate, and easily self-administered. Its development pipeline includes platforms for the rapid testing of COVID-19, influenza and other viruses. Gemina is focused on infectious respiratory diseases and the recovery from them. It has developed a first-generation technology (the Generation 1 Technology), which it has included within an initial demonstration product namely: a point-of-care lateral flow assay to test whether a person is infected with COVID-19 (the Legio-XTM COVID Rapid Antigen Test).

GLAB Intrinsic Value
0.01 CAD
Overvaluation 87%
Intrinsic Value
Price
G

See Also

What is Gemina Laboratories Ltd's Research & Development?
Research & Development
-1.2m CAD

Based on the financial report for Jan 31, 2025, Gemina Laboratories Ltd's Research & Development amounts to -1.2m CAD.

What is Gemina Laboratories Ltd's Research & Development growth rate?
Research & Development CAGR 3Y
-6%

Over the last year, the Research & Development growth was -38%. The average annual Research & Development growth rates for Gemina Laboratories Ltd have been -6% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett